Plasmalyte: Clinical Trials

2 trials of Plasmalyte, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Plasmalyte: new trials by email Literature Review of Plasmalyte trials Research Report on Plasmalyte

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge
TetraVax-DV-TV003 (TV003), Plasmalyte, Challenge virus ZIKV-SJRP/2016-184 - Zika Virus
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)272024-09-242026-03-09
A Low ChloridE hyperTonic Solution for Brain Edema
Sodium chloride /sodium acetate (16.4%), Sodium chloride (23.4%), PlasmaLyte - Subarachnoid Hemorrhage, Acute Kidney Injury
Phase 1CompletedEmory University592017-06-282023-05-01

Conditions studied

Acute Kidney Injury (1)  ·  Subarachnoid Hemorrhage (1)  ·  Zika Virus Infection (1)

Sponsors

Emory University (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (2)

Top investigators

Anna Durbin, M.D. (1)  ·  Owen Samuels, MD (1)

Results publications

PMID 30428930, PMID 32391156